exRNAdisease

Entry Detail

---



General Information

Database ID: exR0760919 RNA Name: MTRNR2L12 RNA Type: mRNA Chromosome: chr3 Starnd: - Coordinate: Start Site(bp): 96617188 End Site(bp): 96618236 External Links: ENSG00000269028

Disease Information

Disease Name: Glioblastoma Multiforme Disease Category: Cancers MeSH ID: D005909 Type: Neoplasms/Neoplasms, Glandular and Epithelial Alias: Glioblastoma//Glioblastomas//Astrocytoma, Grade IV//Astrocytomas, Grade IV//Grade IV Astrocytoma//Grade IV Astrocytomas//Glioblastoma Multiforme//Giant Cell Glioblastoma//Giant Cell Glioblastomas//Glioblastoma, Giant Cell//Glioblastomas, Giant Cell

Expression Detail

GEO ID: GSE106804 Description: Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles Experimental Design: Cancer vs Control Case Disease Type: Glioblastoma Multiforme Case Disease SubType: NA Case Sample: Glioblastoma Multiforme Control Sample: Healthy Number of Case: 13 Number of Control: 6 Number of Samples: 19

Regulatory Relationship

mRNA targets: Gene Symbol Chromosome Start Site(bp) End Site(bp) Strand ABHD3 chr18 21650901 21704780 - AC010132.3 chr7 42909273 42932174 - AHCYL1 chr1 109984765 110023742 + AC023055.1 chr12 55757275 55827546 - AK3 chr9 4709556 4742043 - ACBD3 chr1 226144679 226186741 - AL049844.1 chr6 143807092 143844617 + ACAA2 chr18 49782164 49813953 - AGPAT3 chr21 43865223 43987592 + AHCY chr20 34280268 34311802 - AKAP1 chr17 57085092 57121346 + A4GALT chr22 42692121 42721298 - AC104452.1 chr3 49416777 49429314 - ABCE1 chr4 145098288 145129524 + ACACA chr17 37084992 37406836 - ADSL chr22 40346500 40390463 + ACAP2 chr3 195274745 195443044 - AC010422.3 chr19 12643831 12648397 - AC007040.2 chr2 70939318 70995336 - ADK chr10 74151202 74709963 + AKR1A1 chr1 45550543 45570049 + AC118549.1 chr1 77562416 77683419 - AGO4 chr1 35808016 35857890 + AC005943.1 chr19 1578339 1605445 - ADNP2 chr18 80109262 80147523 + AC009133.6 chr16 29812261 29820092 + AL139300.1 chr14 103562962 103685924 + AC048338.1 chr12 122207779 122266423 - AK4 chr1 65147549 65232145 + AAAS chr12 53307456 53324864 - miRNA targets: miRNA Symbol Chromosome Start Site(bp) End Site(bp) Strand hsa-miR-3654 chr7 133034860 133034878 - hsa-miR-4426 chr1 192716333 192716349 + hsa-miR-4485-3p chr11 10508277 10508296 - hsa-miR-4709-3p chr14 74480135 74480157 - hsa-miR-6747-3p chr11 62567011 62567031 - circRNA targets: NA lncRNA targets: lncRNA Symbol Chromosome Start Site(bp) End Site(bp) Strand AC005618.1 chr5 141326210 141329357 + AC005899.4 chr17 32328441 32329395 + AC007365.1 chr2 64644612 64646698 + AC007780.1 chr17 68413623 68524949 + AC018521.1 chr17 47945424 47981736 + AC026191.1 chr3 9292588 9363303 - AC048341.2 chr12 62603909 62604399 + AC068205.2 chr11 43578889 43840030 + AC068768.1 chr12 123262060 123262402 + AC069281.2 chr7 100572232 100578700 - AC087190.3 chr16 9104848 9113181 + AC099329.1 chr3 42785087 42852428 - AC104257.1 chr8 131308545 131317632 + AC104461.1 chr1 200333193 200478669 + AC106864.1 chr4 112693047 112706810 - AC126365.1 chr17 20788071 20789584 + AC245014.3 chr1 145281116 145281462 + AD000090.1 chr19 35557956 35581954 + AF106564.1 chr8 24912165 24914717 - AL022311.1 chr22 37876148 37895563 + AL022322.2 chr22 38130216 38150612 + AL049796.1 chr1 93847174 93848939 + AL135791.1 chr10 37857740 37859110 + Display:

Experiment Detail

GEO ID: NA Sample Source: NA Source Fraction: NA Platform: NA Method: NA Num of detected RNA Type: NA Num of detected RNAs of this Type: NA Sample treatment protocol: NA RNA Extract protocol: NA RNA library preparation protocol: NA

Reference

PMID: 29330365 Title: Engineered nanointerfaces for microfluidic isolation and molecular profiling of tumor-specific extracellular vesicles. Author: Re¨¢tegui E, van der Vos KE, Lai CP, Zeinali M, Atai NA, Aldikacti B, Floyd FP Jr, H Khankhel A, Thapar V, Hochberg FH, Sequist LV, Nahed BV, S Carter B, Toner M, Balaj L, T Ting D, Breakefield XO, Stott SL. Journal: Nat Commun. 2018 Jan 12;9(1):175. Description: Tumor-derived EVs have the potential to be utilized as disease-specific biomarkers, and genes specific to GBM as well as transcripts that are hallmarks for the four genetic subtypes of the disease.